Effect of Pyrotinib on Levels of Tumor Markers in Patients with HER2-Positive Breast Cancer
Biao Zhong1*, MengMeng Zou1, Jie Zeng1, Juan Bai2, YongJun Deng3, Xin Li4 and YongQin Wang5
1Department of Breast and Thyroid Surgery, Affiliated Hospital of Chengdu University, Chengdu, 610000, China
2Department of Medical Oncology, Affiliated Hospital of Chengdu University, Chengdu, 610000, China
3Department of Ultrasound Medicine, Affiliated Hospital of Chengdu University, Chengdu, 610000, China
4Department of Pathology, Affiliated Hospital of Chengdu University, Chengdu, 610000, China
5Department of Radiology, Affiliated Hospital of Chengdu University, Chengdu, 610000, China
* Corresponding author: 18782231120@163.com
Fig. 1.
Survival rates between study groups.
Fig. 2.
Proportion of various adverse reactions. (A) control group; (B) observation group.